ALB and cancer: Patients with chronic kidney disease, cerebrovascular disease, cancer, advanced dementia, delirium, polypharmacy, weight loss history, functional dependency, pressure ulcers and low albumin levels were more likely to die over the course of follow-up (Table 1).